Clinical Trials Logo

Rocuronium clinical trials

View clinical trials related to Rocuronium.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT05515835 Enrolling by invitation - Body Composition Clinical Trials

Relationship Between Effect Duration of Rocuronium and Body Composition Analysis Data.

Start date: September 5, 2022
Phase:
Study type: Observational

The induction dose of rocuronium is typically decided based on the patient's body weight, but the effect duration of rocuronium is variable. Some studies suggest that body composition analysis data, such as skeletal muscle mass or total body water, may correlate better with the duration time of rocuronium. Therefore, we plan to analyse body composition in patients undergoing total intravenous general anesthesia, give the patients a fixed dose (50mg) of rocuronium, and check the correlation between duration time of rocuronium and body composition analysis data.

NCT ID: NCT04760912 Enrolling by invitation - Muscle Weakness Clinical Trials

General Anesthesia With and Without Muscle Relaxation and Muscle Strength Recovery

Start date: April 1, 2020
Phase: N/A
Study type: Interventional

Neuromuscular blocking agents are often used during general anesthesia. Also, general anesthesia may be performed without use of neuromuscular blocking agents. Avoiding neuromuscular relaxation enables better muscle strength recovery.